文献速递中毒与环境急症重症综合管理与镇静镇痛

新南威尔士州中毒性醇类中毒的管理:一项回顾性研究

Management of toxic alcohol poisoning in New South Wales: a retrospective study.
PubMed 文献 · Clin Toxicol (Phila) · 2025-10-08
一句话结论中毒性醇类中毒并发症常见(56%),从就诊到启动酒精脱氢酶抑制中位4小时,延迟与并发症相关。

该回顾性研究纳入2015至2023年间新南威尔士州毒物信息中心和六家三级临床毒理学服务机构接诊的、符合治疗指征的中毒性醇类中毒患者39例(疑似259例中)。摄入物包括乙二醇31例、二甘醇5例、甲醇3例。从就诊到启动酒精脱氢酶抑制的中位时间为4小时(IQR 2-6小时,n=33)。5例使用甲吡唑,28例使用乙醇治疗;接受乙醇治疗≥24小时的23例中,10例(43%)至少出现两次亚治疗浓度。25例接受体外治疗,中位启动时间7小时(IQR 4-11小时,n=24)。22例(56%)出现并发症:急性肾损伤21例、神经毒性10例、死亡4例。作者认为就诊、诊断和治疗启动的延迟似乎与并发症发生相关。

要点

  • 39例中毒性醇类中毒中,乙二醇31例、二甘醇5例、甲醇3例;22例(56%)出现并发症,包括急性肾损伤21例、神经毒性10例、死亡4例。
  • 从就诊到启动酒精脱氢酶抑制的中位时间为4小时(IQR 2-6小时,n=33),作者认为延迟与并发症相关。
  • 接受乙醇治疗≥24小时的23例中,10例(43%)至少出现两次亚治疗乙醇浓度,提示乙醇方案监测复杂。
  • 25例接受体外治疗,中位启动时间7小时(IQR 4-11小时,n=24)。
  • 18例乙醇治疗患者(64%)中,作者认为使用甲吡唑可能有利,包括避免ICU入住8例、简化转运监测11例、延迟和/或免于体外治疗7例。

适用人群与场景

  • 新南威尔士州毒物信息中心和六家三级临床毒理学服务机构接诊的、转诊至临床毒理学家且符合治疗指征的中毒性醇类中毒患者。
  • 2015年至2023年间疑似中毒性醇类中毒259例,其中39例符合纳入标准。

处置流程与药物剂量

  • 酒精脱氢酶抑制:5例使用甲吡唑,28例使用乙醇治疗;从就诊到启动的中位时间4小时(IQR 2-6小时,n=33)。
  • 体外治疗:25例接受体外治疗,中位启动时间7小时(IQR 4-11小时,n=24)。

红旗征与不能漏的情况

  • 急性肾损伤21例、神经毒性10例、死亡4例,并发症常见,作者认为与就诊、诊断和治疗启动延迟相关。

研究设计与关键结果

  • 回顾性研究,纳入39例符合治疗指征的中毒性醇类中毒患者,摄入物为乙二醇31例、二甘醇5例、甲醇3例。
  • 就诊中位时间4小时(IQR 2-10小时,n=23);从就诊到启动酒精脱氢酶抑制中位时间4小时(IQR 2-6小时,n=33)。
  • 5例接受甲吡唑,28例接受乙醇治疗;乙醇治疗≥24小时的23例中,10例(43%)至少出现两次亚治疗乙醇浓度。
  • 25例接受体外治疗,中位启动时间7小时(IQR 4-11小时,n=24)。
  • 22例(56%)出现并发症:急性肾损伤21例、神经毒性10例、死亡4例。
  • 18例乙醇治疗患者(64%)中,作者认为甲吡唑可能有利:避免ICU入住8例、简化转运监测11例、延迟和/或免于体外治疗7例。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为就诊、诊断和治疗启动的延迟似乎与并发症发生相关。
  • 在18例乙醇治疗患者(64%)中,作者认为使用甲吡唑可能有利,包括避免ICU入住(8例)、简化转运监测(11例)、延迟和/或免于体外治疗(7例)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Toxic alcohol poisoning causes significant morbidity and mortality, especially when treatment is delayed. We describe the epidemiology, management and outcomes of clinically significant toxic alcohol poisonings in New South Wales. We also evaluate the frequency and choice of antidotal therapies (fomepizole versus ethanol) and complications of poisoning and treatment.

METHODS: We searched databases of the New South Wales Poisons Information Centre, and six tertiary clinical toxicology services. We included toxic alcohol poisonings referred to a clinical toxicologist, which met the indications for treatment. Data extracted included demographics, exposures, management, and outcomes.

RESULTS: Among 259 patients presenting with suspected toxic alcohol poisoning between 2015 and 2023, 39 fulfilled the inclusion criteria. Ingestions included ethylene glycol (n = 31), diethylene glycol (n = 5), and methanol (n = 3). The median time to presentation was 4 h (IQR: 2-10 h; n = 23). The median time from hospital presentation to initiating alcohol dehydrogenase inhibition was 4 h (IQR: 2-6 h; n = 33). Five patients received fomepizole and 28 received ethanol therapy. In 23 patients receiving ethanol for ≥24 h, 10 (43%) had at least two subtherapeutic ethanol concentrations. Twenty-five patients received extracorporeal treatments, initiated within a median of 7 h (IQR: 4-11 h; n = 24). Twenty-two patients (56%) developed complications: acute kidney injury (n = 21), neurotoxicity (n = 10), and death (n = 4). In 18 ethanol-treated patients (64%), the use of fomepizole could have been advantageous, including avoiding intensive care admission (n = 8), simplifying monitoring during transport (n = 11), and delaying and/or foregoing extracorporeal treatment (n = 7).

DISCUSSION: Most patients treated for toxic alcohol poisoning had proven poisonings, biochemically or by history. Complications were common for multiple reasons, including possible delays in diagnosis and treatment.

CONCLUSION: The management of patients with toxic alcohol poisonings is resource-intensive, and toxicity is associated with clinically sig-nificant morbidity and mortality. Delays in presenta-tion, diagnosis and treatment initiation appear to be associated with the development of complications.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Beaulieu J, Chandru P, Berling I, et al. Management of toxic alcohol poisoning in New South Wales: a retrospective study. Clin Toxicol (Phila). 2025. PMID: 41060103. doi:10.1080/15563650.2025.2560540

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。